Skip to main content
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.28
+0.39 (1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed

HRMY Revenue

Harmony Biosciences Holdings had revenue of $186.04M in the quarter ending September 30, 2024, with 16.08% growth. This brings the company's revenue in the last twelve months to $681.88M, up 25.83% year-over-year. In the year 2023, Harmony Biosciences Holdings had annual revenue of $582.02M with 32.93% growth.

Revenue (ttm)
$681.88M
Revenue Growth
+25.83%
P/S Ratio
2.88
Revenue / Employee
$2,771,866
Employees
246
Market Cap
1.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amphastar Pharmaceuticals 723.55M
Supernus Pharmaceuticals 651.97M
UFP Technologies 461.85M
Mirum Pharmaceuticals 307.03M
ImmunityBio 7.33M
CG Oncology 684.00K
Revenue Rankings

HRMY News

More News